Sunday Spotlight, ADVISORY

EDITORS:

The following story has moved as this week's Sunday Spotlight, a feature showcasing the best off-the-news enterprise in the AP report:

CHINA-VACCINES

BEIJING — Hundreds of thousands of people have taken one of the four leading vaccine candidates in China. Kan Chai, a popular journalist and writer in September, shared his experience of signing up for a state-backed firm’s vaccine candidate, CNBG. It is happening outside the confines of clinical trials it seems, raising questions of safety and ethics. The Chinese government has not made clear how these hundreds of thousands of people have had their health tracked, how they were informed and under what conditions they were taking the vaccine. Globally, China has the most number of vaccine candidates in advanced stage 3 clinical trials. By Huizhong Wu and Sam McNeil. SENT: 1,300 words, AP Photos.

—The AP